Position in BMY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,110,740
-$1,863,232 QoQ
Shares Held
19,277
-60.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,107
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 3%
None 4%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First National Trust Co holds $128,309,128 across 8 Drug Manufacturers - General names. BMY ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,798 | $36,940,047 | |
| 2 | JNJ |
Johnson & Johnson
|
125,659 | $31,913,616 | |
| 3 | MRK |
Merck & Co., Inc.
|
179,140 | $23,019,489 | |
| 4 | ABBV |
AbbVie Inc.
|
74,068 | $18,638,470 | |
| 5 | AMGN |
Amgen Inc
|
42,011 | $15,213,022 | |
| 6 | PFE |
Pfizer Inc
|
52,136 | $1,255,434 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
19,277 | $1,110,740 | |
| 8 | NVS |
Novartis AG
|
1,393 | $218,310 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,110,740 | 19,277 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,973,972 | 49,035 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,810,327 | 52,101 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,415,736 | 53,564 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $1,750,779 | 37,822 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,467,289 | 40,454 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $3,122,676 | 55,210 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,117,179 | 60,247 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,752,690 | 66,282 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $5,061,773 | 93,339 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $10,903,733 | 212,507 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $14,498,508 | 249,802 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $20,311,670 | 317,618 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $21,641,146 | 312,237 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $22,302,844 | 309,977 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $21,490,150 | 302,295 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $22,891,407 | 297,291 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $16,146,129 | 221,089 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $11,433,742 | 183,380 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $10,178,363 | 172,019 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $11,242,731 | 168,254 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $10,832,287 | 171,587 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $11,473,440 | 184,966 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $9,938,383 | 164,843 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $9,121,408 | 155,126 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $8,064,017 | 144,672 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||